Interní Med. 2009; 11(1): 34-35

Facial dermatoses - review and treatment (part II)

doc. MUDr. Jarmila Rulcová CSc
Dermatovenerologická klinika, FN Brno

The following second par of the article about facial dermatoses focuses mainly on those disease that occur not only in dermatology clinics

but also in other specialities. Rosacea, demodikosis, perioral dermatitis and seborhoic dermatitis belong to those diseases. Effective local

and systemic therapeutic strategies are discussed.

Keywords: Key words: rosacea faciei, demodicosis, dermatitis perioralis, dermatitis seborrhoica, etiopathogenetic factors, therapy.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rulcová J. Facial dermatoses - review and treatment (part II). Interní Med. 2009;11(1):34-35.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Conde JF, Yelverton CB, Balkrishnan R, et al. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. Journal of Drugs in Dermatology 2007; 6 (5): 495-498. Go to PubMed...
    2. Dakovic Z, Vesic S, Vukovic J, et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series. Acta Dermatovenerologica Alpina, Panonica et Adriatica 2007; 16 (2): 83-86.
    3. Elewski BE, Fleischer AB, Pariser DM. Comparison of 15% Azelaic Acid Gel and 0,75% Metronidazole Gel in the Topical Treatment of Papulopustular Rosacea. Results of a Randomized Trial. Arch Dermatol. 2003; 139: 1444-1450. Go to original source... Go to PubMed...
    4. Gupta AK, Gover MD. Azelaic acid (15% gel) in the treatment of acne rosacea. International journal of Dermatology 2007; 46 (5): 533-538. Go to original source... Go to PubMed...
    5. Chu Cy. An open - label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. Journal of the Europan Academy of Dermatology et Venerology 2007; 21 (4): 484-490. Go to original source... Go to PubMed...
    6. Moraes AP, Arruda EA, Vitoriano MA, et al. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. Journal of the Europan Academy of Dermatology et Venerology 2007; 21 (5): 596-601. Go to original source... Go to PubMed...
    7. Plewig G, Kligman AM. Acne and Rosacea, 3rd Completely Revised and Enlarged Edition. Springer-Verlag Berlin Heidelberg New York, 2000: 744 s. Go to original source...
    8. Rodriguez-Martin M, Saez-Rodriguez M, Carnerero-Rodriguez A, et al. Treatment of perioral dermatitis with topical pimecrolimus. Journal of the American Academy of Dermatology 2007; 56 (3): 529-530. Go to original source... Go to PubMed...
    9. Sanchez JL, Berlingeri-Ramos AC, Dueno DV, et al. Granulomatous rosacea. American Journal of dermatopathology 2008, 30 (1): 6-9. Go to original source... Go to PubMed...
    10. Swinyer LJ, Decroix J, Langner A, et al. Ketoconazole gel 2% in the treatment of moderate to severe seborrhoic dermatitis. Cutis 2007; 79 (6): 475-482. Go to PubMed...
    11. Štork J. Akné a příbuzné dermatózy. In Štork J. et al. Dermatovenerologie. Galén Karolinum Praha 2008: 291-296.
    12. Zuuren EJ, Gupta AK, Gover MD, et al. Systematic review of rosacea treatments. Journal of the American Academy of Dermatology 2007; 56 (1): 10. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.